Literature DB >> 31428410

To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool.

Hidekazu Suzuki1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31428410      PMCID： PMC6683642          DOI： 10.1177/2050640619856188

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  8 in total

1.  A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.

Authors:  Bu'Hussain Hayee; Kerry-Lee Watson; Sanchika Campbell; Anna Simpson; Emma Farrell; Penelope Hutchings; Patricia Macedo; Felicity Perrin; Kevin Whelan; Caroline Elston
Journal:  United European Gastroenterol J       Date:  2019-08       Impact factor: 4.623

Review 2.  United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).

Authors:  J Matthias Löhr; Enrique Dominguez-Munoz; Jonas Rosendahl; Marc Besselink; Julia Mayerle; Markus M Lerch; Stephan Haas; Fatih Akisik; Nikolaos Kartalis; Julio Iglesias-Garcia; Jutta Keller; Marja Boermeester; Jens Werner; Jean-Marc Dumonceau; Paul Fockens; Asbjorn Drewes; Gürlap Ceyhan; Björn Lindkvist; Joost Drenth; Nils Ewald; Philip Hardt; Enrique de Madaria; Heiko Witt; Alexander Schneider; Riccardo Manfredi; Frøkjer J Brøndum; Sasa Rudolf; Thomas Bollen; Marco Bruno
Journal:  United European Gastroenterol J       Date:  2017-01-16       Impact factor: 4.623

3.  Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.

Authors:  Douglas A Drossman; William L Hasler
Journal:  Gastroenterology       Date:  2016-05       Impact factor: 22.682

4.  Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation.

Authors:  S Fukudo; A Nakajima; Y Fujiyama; M Kosako; A Nakagawa; H Akiho; Y Nakashima; J M Johnston; H Miwa
Journal:  Neurogastroenterol Motil       Date:  2018-05       Impact factor: 3.598

5.  Classification of functional dyspepsia based on concomitant bowel symptoms.

Authors:  J Matsuzaki; H Suzuki; K Asakura; Y Fukushima; J M Inadomi; T Takebayashi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2012-01-11       Impact factor: 3.598

6.  Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial.

Authors:  Yasushi Fukushima; Hidekazu Suzuki; Juntaro Matsuzaki; Arihiro Kiyosue; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

7.  Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis.

Authors:  Katharina Staufer; Emina Halilbasic; Peter Hillebrand; Solveig Harm; Stefan Schwarz; Peter Jaksch; Danijel Kivaranovic; Walter Klepetko; Michael Trauner; Lili Kazemi-Shirazi
Journal:  United European Gastroenterol J       Date:  2018-05-17       Impact factor: 4.623

8.  High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan.

Authors:  Shin Fukudo; Hiroto Miwa; Atsushi Nakajima; Yoshikazu Kinoshita; Masanori Kosako; Kenta Hayashi; Hiraku Akiho; Kentaro Kuroishi; Jeffrey M Johnston; Mark Currie; Toshifumi Ohkusa
Journal:  Neurogastroenterol Motil       Date:  2018-10-23       Impact factor: 3.598
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.